As previously reported, mTOR activation increases cell proliferation, whereas the blockade of mTOR signalling by rapamycin analogues slows tumour growth and increases survival in the HCC xenograft model [25]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.